# ScoreItem: Ecodopplercardiograma - E/e' M√©dia

**ID:** `019bf31d-2ef0-74ae-b307-8cb78e736f5f`
**FullName:** Ecodopplercardiograma - E/e' M√©dia (Exames - Imagem)
**Unit:** ratio

**Preparation Metadata:**
- Quality Grade: **FAIR**
- Total Chunks: 30 de 25 artigos
- Avg Similarity: 0.498

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `019bf31d-2ef0-74ae-b307-8cb78e736f5f`.**

```json
{
  "score_item_id": "019bf31d-2ef0-74ae-b307-8cb78e736f5f",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto cl√≠nico: 1-9 pts
- Alto impacto cl√≠nico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Crit√©rios: gravidade/mortalidade (40%), preval√™ncia (30%), intervencionabilidade (30%)

---

### Contexto Cient√≠fico

**ScoreItem:** Ecodopplercardiograma - E/e' M√©dia (Exames - Imagem)
**Unidade:** ratio

**30 chunks de 25 artigos (avg similarity: 0.498)**

### Chunk 1/30
**Article:** Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update From the American Society of Echocardiography (2025)
**Journal:** Journal of the American Society of Echocardiography
**Section:** abstract | **Similarity:** 0.554

Updated guidelines for the evaluation of left ventricular diastolic function incorporating LAVI as a key parameter in the assessment algorithm. LAVI is an integral part of routine evaluation of patients with dyspnea or heart failure, providing powerful predictive marker of LV diastolic dysfunction.

---

### Chunk 2/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.551

N-terminalproB-typenatriureticpeptide;BSA,bodysurfacearea;SBP,systolicbloodpressure;DBP,diastolicbloodpressure;eGFR,estimatedglomelurarltrationrate;LAVi,leftatrialvolumeindex;e,earlydiastolictransmitralowvelocity;E‚Ä≤,earlydiastolicmitralannularvelocity;TAPSE,tricuspidannularplaneexcursion;PASP,pulmonaryarterialsystolicpressure;RVOT-AT,rightventricularoutowtractaccelerationtime;VO2peak,peakoxygenconsumption;NYHA,NewYorkHeartAssociation;AF,atrialbrillation;ACE-I,angiotensin-converting-enzymeinhibitors;ARBs,angiotensin-receptorblockers;MRA,mineralocorticoid-receptorantagonist;ICD,implantablecardioverter-debrillator;CRT,cardiacresynchronizationtherapy;IGF-1D,IGF-1deciency;DHEA-SD,DHEA-Sdeciency.

---

### Chunk 3/30
**Article:** Relationship of TAPSE Normalized by Right Ventricular Area With Pulmonary Compliance, Exercise Capacity, and Clinical Outcomes (2024)
**Journal:** Circulation: Heart Failure
**Section:** abstract | **Similarity:** 0.539

Study introducing normalized TAPSE values (TAPSE/RVA-D and TAPSE/RVA-S) for improved prognostic assessment. TAPSE/RVA-D <1.1 and TAPSE/RVA-S <1.5 predicted adverse cardiovascular outcomes, providing better discrimination than traditional TAPSE alone. Demonstrates relationship between normalized TAPSE and pulmonary compliance and exercise capacity in heart failure patients.

---

### Chunk 4/30
**Article:** Aula Afonso Salgado - Sistema nervoso aut√¥nomo (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.530

or progn√≥stico.  
- **Baixa variabilidade** ‚Üí baixa atividade parassimp√°tica, maior carga alost√°tica, pior progn√≥stico.

Ele introduz dois conceitos centrais:

1. **Alostase:**  
   - √© a capacidade do organismo de mobilizar energia para enfrentar os estressores;  
   - na met√°fora de Afonso, √© o ‚Äúcombust√≠vel do carro‚Äù: sem alostase, o paciente n√£o tem ‚Äúgasolina‚Äù para reagir;  
   - a avalia√ß√£o da VFC mede, na pr√°tica, o n√≠vel de alostase.

2. **Carga alost√°tica:**  
   - √© o desgaste acumulado ao longo do tempo decorrente do esfor√ßo cr√¥nico para manter a homeostase;  
   - conecta estresse cr√¥nico a doen√ßas degenerativas e cr√¥nicas n√£o transmiss√≠veis;  
   - idosos, por exemplo, tendem a ter **baixa VFC** e alta carga alost√°tica.

O protocolo ideal de avalia√ß√£o descrito inclui:

- Exame realizado preferencialmente pela manh√£, em jejum, evitando a ingest√£o de medicamentos naquele momento (pois alteram a leitura).

---

### Chunk 5/30
**Article:** Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography (2015)
**Journal:** Journal of the American Society of Echocardiography
**Section:** abstract | **Similarity:** 0.523

Updated guidelines for echocardiographic assessment. Normal LVEF ‚â•54% in women by Simpson method. Sex-specific reference ranges are essential for accurate diagnosis of systolic dysfunction.

---

### Chunk 6/30
**Article:** Tricuspid Annular Plane Systolic Excursion and Pulmonary Arterial Systolic Pressure Relationship in Heart Failure (2013)
**Journal:** Chest
**Section:** abstract | **Similarity:** 0.521

Landmark study demonstrating that TAPSE/PASP ratio improves prognostic resolution in heart failure patients. Shows that TAPSE powerfully reflects RV function and prognosis. Unlike LVEF, TAPSE was an independent predictor of outcome in chronic heart failure. Establishes the importance of RV-PA coupling assessment beyond simple TAPSE measurement.

---

### Chunk 7/30
**Article:** Hipertens√£o Arterial Sist√™mica II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.510

o de Diagn√≥stico:
1.  **Hist√≥rico M√©dico:** O conte√∫do √© uma palestra m√©dica sobre fatores de risco cardiovascular contempor√¢neos, n√£o uma consulta com um paciente espec√≠fico.
2.  **Hist√≥rico de Medica√ß√£o:** Inserir mais aqui
## Subjetivo:
O conte√∫do √© uma palestra m√©dica e n√£o cont√©m queixas subjetivas de um paciente.
## Objetivo:
O conte√∫do √© uma palestra m√©dica e n√£o cont√©m achados de exames de um paciente espec√≠fico. O palestrante menciona seus pr√≥prios resultados de exames como exemplo:
-   **√çndice de √îmega-3:** 6.7 (ideal entre 3 e 14).
-   **Rela√ß√£o √îmega-6 para √îmega-3:** 5:1 (ideal de 2:1 a 3:1), apesar da suplementa√ß√£o.
## Diagn√≥stico Prim√°rio:
-   **Avalia√ß√£o:** O texto √© uma apresenta√ß√£o educacional sobre fatores de risco inflamat√≥rios e metab√≥licos para doen√ßas vasculares, que s√£o frequentemente negligenciados na cardiologia tradicional. Os principais fatores discutidos incluem:
    -   Desequil√≠brio entre √îmega-3 e √îmega-6.

---

### Chunk 8/30
**Article:** Monitoring of Tissue Oxygenation: an Everyday Clinical Challenge (2018)
**Journal:** Frontiers in Medicine
**Section:** other | **Similarity:** 0.507

ction imbalance that could be 
detected by low ScvO2 (24). In a clinical study aer myocardial infarction in patients with heart failure and cardiogenic shock, SvO2 was 43%, while in patients with heart failure without shock, it was 56% compared to patients without heart failure with an 
SvO2 of 70% (25). It may also be useful in patients with cardio-genic shock requiring the support by intraaortic balloon counter 
pulsation. In a study during weaning period, intraaortic balloon 

4
Molnar and Nemeth
Frontiers in Medicine | www.frontiersin.orgJanuary 2018 | Volume 4 | Article 247
pump assist ratio was decreased from 1:1 to 1:3. In the weaning failure group, decreased support was accompanied by a drop in ScvO2, while it remained constant in the successful group (26). In patients with chronic heart failure, ScvO2 can be chronically low.

---

### Chunk 9/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.504

¬±SDMean¬±SDMean¬±SDAge(years)66.18¬±10.2668.93¬±9.74564.89¬±10.3250.12NTproBNP(pg/ml)2597.05¬±4093.042794.47¬±3380.142504.52¬±4409.550.72
BSA(m2)1.70¬±0.161.68¬±0.11.71¬±0.190.34SBP(mmHg)123.29¬±17.82121.32¬±16.86124.24¬±18.370.53DBP(mmHg)75.46¬±12.3975.05¬±9.5175.65¬±13.650.85
eGFR(ml/min)68.61¬±34.2854.27¬±23.0275.55¬±36.760.001
Haemoglobin(g/dl)12.85¬±1.5312.50¬±1.2113.01¬±1.650.13Albumin(%)56.8¬±5.256.6¬±7.756.9¬±3.70.9Testosterone(ng/dl)48.80¬±61.8613.60¬±6.6362.55¬±68.16<0.001Ejectionfraction(%)33.81¬±6.4633.20¬±7.6634.10¬±5.850.53
LAVi(ml/m2)49.46¬±25.5755.51¬±30.2446.63¬±22.770.17e/E‚Ä≤14.68¬±9.9613.04¬±4.9512.53¬±6.400.16TAPSE(mm)18.82¬±4.5117.78¬±4.2619.31¬±4.560.12
PASP(mmHg)34.38¬±13.2537.69¬±13.7232.84¬±12.840.98
RVOT-AT(ms)103.27¬±36.47112.11¬±34.7497.15¬±37.730.35TAPSE/PASP(mm/mmHg)0.63¬±0.290.53¬±0.220.68¬±0.320.008Pericardialeffusion14(15.20%)7(23.30%)7(10.93%)0.11
VO2peak(ml*kg1*min1)(n=67)20.61¬±4.7018.89¬±4.9221.31¬±4.920.03NYHAclassII66(70.21%)21(70.00%)45(70.31

---

### Chunk 10/30
**Article:** Aula Afonso Salgado - Sistema nervoso aut√¥nomo (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.501

ia√ß√£o descrito inclui:

- Exame realizado preferencialmente pela manh√£, em jejum, evitando a ingest√£o de medicamentos naquele momento (pois alteram a leitura).  
- Repeti√ß√£o do exame em **3 a 5 ocasi√µes** em condi√ß√µes semelhantes, para obter dados de ‚Äúpadr√£o ouro‚Äù (maior confiabilidade).  

A partir do ECG, softwares especializados analisam a VFC tanto no **dom√≠nio do tempo** quanto no **dom√≠nio da frequ√™ncia**:

- No dom√≠nio do tempo, o par√¢metro mais citado √© o **SDNN** (desvio padr√£o dos intervalos NN), que √© uma raiz quadrada aplicada √† distribui√ß√£o dos intervalos.  
- SDNN mais alto indica maior variabilidade; SDNN baixo indica rigidez do ritmo, associada a pior progn√≥stico.

No dom√≠nio da frequ√™ncia, embora Afonso n√£o detalhe numericamente, ele indica o uso de t√©cnicas matem√°ticas como:

- **R√°pida transformada de Fourier (FFT)**,  
- **wavelet transform**,  
- **ritmogramas** (conceito de origem russa).

---

### Chunk 11/30
**Article:** Cardiologia VIII (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.501

# Cardiologia VIII

**Source:** https://web.plaud.ai/share/43b41764908850761::YXdzOnVzLXdlc3QtMg

---

## Reasoning Summary

## An√°lise de Exames, Fatores de Risco e Estrat√©gias Terap√™uticas em Cardiologia
### 1. Interpreta√ß√£o de Exames e Marcadores de Risco Cardiovascular
- **Princ√≠pio da Probabilidade e Contexto Cl√≠nico:** A an√°lise de exames laboratoriais deve seguir o princ√≠pio de que a medicina √© uma "ci√™ncia da probabilidade". Os valores devem ser interpretados dentro do contexto cl√≠nico do paciente (hist√≥ria, exame f√≠sico, idade) e n√£o como n√∫meros isolados a serem "corrigidos". √â crucial n√£o se fixar em atingir valores "√≥timos" em todos os exames, pois o exame √© um desfecho substituto e a prioridade √© o paciente como um todo.

---

### Chunk 12/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.499

(mm/mmHg)0.63¬±0.290.53¬±0.220.68¬±0.320.008Pericardialeffusion14(15.20%)7(23.30%)7(10.93%)0.11
VO2peak(ml*kg1*min1)(n=67)20.61¬±4.7018.89¬±4.9221.31¬±4.920.03NYHAclassII66(70.21%)21(70.00%)45(70.31%)0.98III23(24.46%)7(23.33%)16(25.00%)0.87
IV5(5.33%)2(6.67%)3(4.69%)0.65Aetiology(ischaemic)27(28.7%)17(56.7%)10(15.6%)0.01Yearofdisease5[2‚Äì10.75]4[1‚Äì9.75]7[2.75‚Äì12]0.1AF11(22.4%)4(13.33%)7(10.90%)0.73
Beta-blockers66(91.7%)24(72.00%)42(65.60%)0.15
ACE-I31(43.1%)12(40.00%)19(29.70%)0.22ARBs26(36.1%)9(30.00%)17(26.60%)0.72MRA26(36.1%)8(26.70%)18(28.12%)0.88
ICD26(36.6%)8(26.66%)18(28.10%)0.88
CRT10(14.1%)1(3.33%)9(14.10%)0.15IGF-1D50(53.2%)16(53.3%)34(53.1%)0.98DHEA-SD73(77.7%)29(97.7%)44(68.7%)0.01
TypeIIdiabetes26(27.7%)6(20%)20(31.2)0.37Abbreviations:TD,testosteronedeciency;NTproBNP,N-terminalproB-typenatriureticpeptide;BSA,bodysurfacearea;SBP,systolicbloodpressure;DBP,diastolicbloodpressure;eGFR,estimatedglomelurarltrationrate;LAVi,leftatrialvolumeindex;e,earlydiastolictransmit

---

### Chunk 13/30
**Article:** Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: 2025 ASE Update (2025)
**Journal:** Journal of the American Society of Echocardiography
**Section:** abstract | **Similarity:** 0.499

Updated guidelines for right heart echocardiographic assessment introducing graded severity classification for TAPSE. Normal TAPSE values are ‚â•2.5 cm, with graded severity ranges allowing reporting as normal, mild, moderate, or severely reduced. Emphasizes multiparametric approach including TAPSE, S', FAC, 3D RVEF, and RV-PA coupling for comprehensive right ventricular function assessment.

---

### Chunk 14/30
**Article:** Capnodynamics - noninvasive cardiac output and mixed venous oxygen saturation monitoring in children (2023)
**Journal:** Frontiers in Pediatrics
**Section:** results | **Similarity:** 0.493

esasintheclinicalstudy.Thistimetheinvasivegoldstandard,transpulmonaryarteryowprobe,wasusedasreference.Theagreementofabsolutevaluesshowedameanpercentageerrorof31%,indicatingacceptableagreement.Inaddition,thecapnodynamicmethodhada100%concordanceratewiththegold
standardindicatingitsabilitytodetectthesamechangesinCOasthereferencemethodin100%ofthecases.TheresultspointstowardsamorereliableperformanceofthecapnodynamicmethodinassessingCOandchangeinCOthansuprasternalDopplerperformedbyanexperiencedcardiacsonographer.Figure3belowshowsatimeplotofthecapnodynamicmethodagainstCOTS(A)intheexperimentalstudyandagainstsuprasternal2DDopplerintheclinicalstudy(B)inresponsetoPEEPexposureandatropine.Anadditionalclinicalvalidationstudyininfantshasbeenperformed,usingtransesophagealDoppler(CardioQ-ODM+¬Æ,KarlssonandL√∂nnqvist10.3389/fped.2023.1111270FrontiersinPediatrics04frontiersin.org

DeltexMedicalLtd,Chichester,UnitedKingdom)asreference.15infants(medianageandweight8monthsand9kgrespectively,smallest3.7kg)we

---

### Chunk 15/30
**Article:** Dislipidemias II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.490

dade, inatividade f√≠sica, press√£o arterial e dislipidemia.
- A inflama√ß√£o √© indicada por marcadores como a Prote√≠na C-Reativa (PCR), onde um valor de 5 j√° √© considerado elevado, e a Interleucina 6 (exemplo de paciente com 8.45).
- A resposta anti-inflamat√≥ria √© medida pela Interleucina 10, com um valor de corte de 3,5 (abaixo disso √© um risco) e um exemplo de paciente com 6.44.
- A sa√∫de do endot√©lio √© avaliada pelo √≥xido n√≠trico, que deve estar em 8.8; um paciente com 4.8 j√° apresenta disfun√ß√£o sist√™mica.
- A LDL oxidada √© um marcador cr√≠tico, com um limite saud√°vel de 133, enquanto pacientes de alto risco podem apresentar valores extremos, como 1000.
**Achados Adicionais**
- Existem cinco par√¢metros cl√°ssicos para definir a s√≠ndrome metab√≥lica.
- O alvo de LDL para pacientes de alto risco, segundo as diretrizes atuais, √© de 50.

---

### Chunk 16/30
**Article:** Aula Afonso Salgado - Sistema nervoso aut√¥nomo (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.488

## Avalia√ß√£o Funcional e Diagn√≥stico via Variabilidade da Frequ√™ncia Card√≠aca (VFC)

No eixo diagn√≥stico, Afonso apresenta a **variabilidade da frequ√™ncia card√≠aca (VFC)** como o principal **biomarcador funcional** da integridade do SNA. A VFC √© medida a partir de um eletrocardiograma simples e n√£o invasivo, analisando-se os intervalos entre batimentos (intervalos NN). As varia√ß√µes naturais desses intervalos refletem a flexibilidade neurocard√≠aca.

Segundo a defini√ß√£o adotada pela Associa√ß√£o Americana de Cardiologia, a VFC √© a **medida da fun√ß√£o neurocard√≠aca** resultante da intera√ß√£o reflexa entre cora√ß√£o e c√©rebro, fornecendo dados din√¢micos do estado do SNA. Afonso resume:

- **Alta variabilidade** ‚Üí alta atividade parassimp√°tica, melhor resili√™ncia, melhor progn√≥stico.  
- **Baixa variabilidade** ‚Üí baixa atividade parassimp√°tica, maior carga alost√°tica, pior progn√≥stico.

Ele introduz dois conceitos centrais:

1.

---

### Chunk 17/30
**Article:** Optimal Peak Systolic Velocity Thresholds for Predicting Internal Carotid Artery Stenosis Greater than or Equal to 50%, 60%, 70%, and 80% (2016)
**Journal:** Journal of Stroke and Cerebrovascular Diseases
**Section:** abstract | **Similarity:** 0.488

The research established optimal peak systolic velocity measurements for detecting various degrees of internal carotid artery stenosis. Testing 127 arterial specimens, researchers identified specific thresholds: 130 cm/s, 160 cm/s, 200 cm/s, and 270 cm/s for detecting stenosis at increasing severity levels (‚â•50%, ‚â•60%, ‚â•70%, and ‚â•80% respectively). The findings demonstrated high diagnostic accuracies across all measured thresholds, with sensitivity and specificity values exceeding 85% for each threshold category.

---

### Chunk 18/30
**Article:** Confounders in Identification and Analysis of Inflammatory Biomarkers in Cardiovascular Diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** results | **Similarity:** 0.488

atherosclerosis:Resultsfromaprospective,parallel-groupcohortstudy.Clin.Chim.Acta2015,447,16‚Äì22.[CrossRef]101.Hijazi,Z.;Lindahl,B.;Oldgren,J.;Andersson,U.;Lindb√§ck,J.;Granger,C.B.;Alexander,J.H.;Gersh,B.J.;Hanna,M.;Harjola,V.;etal.RepeatedMeasurementsofCardiacBiomarkersinAtrialFibrillationandValidationoftheABCStrokeScoreOverTime.J.Am.HeartAssoc.2017,6,e004851.[CrossRef]102.Abramson,J.L.;Lewis,C.;Murrah,N.V.;Anderson,G.T.;Vaccarino,V.RelationofC-ReactiveProteinandTumorNecrosisFactor-AlphatoAmbulatoryBloodPressureVariabilityinHealthyAdults.Am.J.Cardiol.2006,98,649‚Äì652.[CrossRef]103.Simundic,A.-M.;Kackov,S.;Miler,M.;Fraser,C.G.;Petersen,P.H.TermsandSymbolsUsedinStudiesonBiologicalVariation:TheNeedforHarmonization.Clin.Chem.2015,61,438‚Äì439.[CrossRef]
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

Biomolecules2021,11,1464
17of17
104.Khuseyinova,N.;Greven,S.;R√ºckerl,R.;Trischler,G.;Loewel,H.;Peters,A.;

---

### Chunk 19/30
**Article:** Vitamin E (Œ±-Tocopherol): Emerging Clinical Role and Adverse Risks of Supplementation in Adults (2025)
**Journal:** Cureus
**Section:** discussion | **Similarity:** 0.487

e in the control group. After 3.5 years of observation, 220 participants had
developed heart failure. The Vitamin E-assigned group showed a nonsignificant 20% increased risk of
developing heart failure; however, participants in the Vitamin E-assigned group with poor ventricular
function (LVEF <50%) had a significant 50% increased risk of heart failure. This finding supports the idea
that Vitamin E can be even more dangerous if given as supplementation in patients with prior adverse
cardiovascular events 
[51]
.
Risk of Stroke (Hemorrhagic vs. Ischemic)
 
Published via Fondazione Paolo Procacci
2025 Kaye et al. Cureus 17(2): e78679. DOI 10.7759/cureus.78679
4
 of 
11

A 2010 systematic review and meta-analysis of randomized, placebo-controlled trials investigated Vitamin
E's effect on stroke incidents.

---

### Chunk 20/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** results | **Similarity:** 0.487

diseasedurationandlowdensitylipoproteincholesterollevels.JAmCollCardiol
1996:28:573‚Äì579.50Pedersen&Saltin
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

CoakleyEH,RimmEB,ColditzG,KawachiI,WillettW.Predictorsofweightchangeinmen:resultsfrom
theHealthProfessionalsFollow-upStudy.IntJObesRelatMetabDisord1998:22:89‚Äì96.CoatsAJ,AdamopoulosS,MeyerTE,ConwayJ,SleightP.Effectsofphysicaltraininginchronicheartfailure.Lancet1990:335:63‚Äì66.CoatsAJ,AdamopoulosS,RadaelliA,McCanceA,MeyerTE,BernardiL,SoldaPL,DaveyP,OrmerodO,ForfarC.Controlledtrialofphysical
traininginchronicheartfailure.

---

### Chunk 21/30
**Article:** Comparing Carotid Artery Velocities with Current ASCVD Risk Stratification: A Novel Approach to Simpler Risk Assessment (2024)
**Journal:** Journal of Epidemiology and Global Health
**Section:** abstract | **Similarity:** 0.484

This prospective study examined 1,636 participants aged 40‚Äì75 years without prior cardiovascular events to explore whether carotid artery blood flow measurements could simplify ASCVD risk assessment. Researchers used duplex ultrasonography to measure flow velocities and compared results against standard 2022 USPSTF risk guidelines. The investigation revealed that end diastolic velocity (EDV) of common carotid artery (CCA) and the peak systolic velocity (PSV) of internal carotid artery (ICA) were inversely and nonlinearly associated with cardiovascular event risk. Optimal cutoff velocities were identified: approximately 23.75 cm/s for CCA-EDV, 81.75 cm/s for ICA-PSV, and 26.75 cm/s for ICA-EDV. Analysis showed U-shaped relationships suggesting these measurements could complement existing risk assessment methods for primary cardiovascular prevention.

---

### Chunk 22/30
**Article:** Hipertens√£o Arterial Sist√™mica (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.482

causa secund√°ria identific√°vel.
**O diagn√≥stico e a classifica√ß√£o da hipertens√£o seguem limiares espec√≠ficos que variam conforme o m√©todo de medi√ß√£o, com est√°gios progressivos que orientam a terapia.**
- A press√£o arterial √© classificada como √≥tima (abaixo de 120/80 mmHg), normal (at√© 129/84 mmHg) e pr√©-hipertens√£o (130-139 / 85-89 mmHg).
- O diagn√≥stico de hipertens√£o √© estabelecido a partir de 14 por 9 mmHg em medi√ß√µes de consult√≥rio, aplic√°vel a indiv√≠duos com mais de 18 anos.
- Os est√°gios da hipertens√£o s√£o definidos como: Est√°gio 1 (a partir de 14/9), Est√°gio 2 (a partir de 16/10) e Est√°gio 3 (acima de 18/11).
- Para exames fora do consult√≥rio, os limiares s√£o mais baixos: 13 por 8 mmHg para o MAPA (24 horas) e 13 por 8,5 mmHg para o MRPA.

---

### Chunk 23/30
**Article:** Fisiologia e Bioqu√≠mica do Sistema Imune II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.481

60 e 90
- [ ] Manter a insulina, o mais baixo poss√≠vel, 6, 7, estourando 8
- [ ] Avaliar a homociste√≠na, pois √© um marcador inflamat√≥rio importante
- [ ] Usar a prote√≠na C-reativa, associado com os n√≠veis de homociste√≠na
- [ ] Verificar os par√¢metros essenciais na avalia√ß√£o inflamat√≥ria
- [ ] Estimar o √≠ndice de glica√ß√£o e o √≠ndice TAIG, baseado nos resultados essenciais
- [ ] Complementar a avalia√ß√£o com TNF-alfa, IL-6, glutationa e malon de alde√≠do
### Tarefas para @
- [ ] Usar um concentrado de C8 ou um mix de C8 e C10, para estimular mais ainda o CP3 e as UCPs (prote√≠nas desacopladoras), diminuir a produ√ß√£o de esp√©cie reativa de oxig√™nio e aumentar a oxida√ß√£o de gordura @
- [ ] Incluir mioinositol, trans-resveratrol e epigalocatequina galato na formula√ß√£o, para diminuir os compostos de glica√ß√£o avan√ßada e a hemoglobina glicada @
- [ ] Fazer uma boa distribui√ß√£o de gordura e trabalhar os √°cidos graxos de cadeia curta, para obter o melhor benef√≠cio p

---

### Chunk 24/30
**Article:** Dislipdemia (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.480

vida e identificar fatores de risco para inflama√ß√£o e disfun√ß√£o endotelial (dieta, estresse, sedentarismo).
- [ ] 2. Utilizar a calculadora MESA Risk para determinar o risco cardiovascular dos pacientes e considerar a solicita√ß√£o do Escore de C√°lcio Coronariano antes de prescrever estatinas em preven√ß√£o prim√°ria.
- [ ] 3. Ao avaliar o risco cardiovascular, solicitar exames avan√ßados como a rela√ß√£o ApoB/ApoA, subpart√≠culas de lipoprote√≠nas e anti-LDL oxidado para uma an√°lise mais aprofundada.
- [ ] 4. Em pacientes de preven√ß√£o prim√°ria, mesmo com colesterol alto, priorizar mudan√ßas no estilo de vida antes de considerar o uso de estatinas.
- [ ] 5. Reservar o uso de estatinas principalmente para pacientes em preven√ß√£o secund√°ria ou de alt√≠ssimo risco, focando nos seus efeitos pleotr√≥picos.
- [ ] 6.

---

### Chunk 25/30
**Article:** Correlation between Ultrasound Peak Systolic Velocity and Angiography for Grading Internal Carotid Artery Stenosis (2024)
**Journal:** Journal of Clinical Medicine
**Section:** abstract | **Similarity:** 0.476

The study evaluated how peak systolic velocity (PSV) measured via duplex ultrasound correlates with angiography findings for assessing internal carotid artery stenosis. Researchers analyzed 47 stenotic lesions using both ultrasound and digital subtraction angiography, applying NASCET and ECST classification protocols. Key findings indicated that a PSV threshold of 200 cm/s was found to be the best criterion for identifying severe NASCET stenoses (‚â•70%), while a threshold of 180 cm/s was the best for ECST stenoses (‚â•80%). However, PSV demonstrated limited reliability for moderate stenoses, suggesting complementary imaging techniques should be employed in such cases.

---

### Chunk 26/30
**Article:** Terapia de Reposi√ß√£o Hormonal com Testosterona XII (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.476

nsiderado alterado (normal > 15 ml/s).
- O tratamento medicamentoso para HPB inclui doses como 0,4 mg de Tansulosina ou 2 a 4 mg de Doxazosina para relaxar a musculatura e melhorar o fluxo urin√°rio.
### Achados Adicionais Chave
- A resson√¢ncia magn√©tica multiparam√©trica 3 Tesla √© uma ferramenta de alta defini√ß√£o, recomendada a partir dos 40 anos para homens com hist√≥rico familiar ou a partir dos 50 anos como rotina para uma avalia√ß√£o prost√°tica precisa.
- A dosagem hormonal salivar oferece uma medi√ß√£o precisa dos horm√¥nios livres, com faixas de refer√™ncia para testosterona (47-150), estradiol (0.6-3) e o quociente estrog√™nico (0.04-1.67), que avalia o equil√≠brio hormonal.
- A escala Gleason, que vai de 1 a 10, mede a agressividade do c√¢ncer de pr√≥stata, com tumores classificados como 8, 9 ou 10 sendo considerados os mais agressivos.
- A hiperplasia prost√°tica √© uma condi√ß√£o que afeta apenas 3 esp√©cies: humanos, c√£es e macacos.

---

### Chunk 27/30
**Article:** The role of red blood cell distribution width (RDW) in cardiovascular risk assessment: useful or hype? (2019)
**Journal:** Annals of Translational Medicine
**Section:** abstract | **Similarity:** 0.476

Red cell distribution width (RDW) has emerged as a prognostic marker across multiple cardiovascular conditions. Reference range 12-15%. Each 1% increase in RDW associates with 1.10-fold higher all-cause mortality risk in heart failure. RDW >15% shows 3-fold increased mortality in CAD, 37% higher stroke risk, and 77% higher atrial fibrillation incidence.

---

### Chunk 28/30
**Article:** Hipertens√£o Arterial Sist√™mica II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.474

il√¢ncia aumentada nas mulheres.**
- Pr√©-menopausa: incid√™ncia de eventos cardiovasculares em mulheres √© muito menor (raz√µes 1:20 a 1:30 versus homens).
- P√≥s-menopausa: aproxima√ß√£o para quase 1:1, refletindo a perda do efeito protetor do estrog√™nio e a mudan√ßa no perfil de risco.
**Additional Key Findings**
- Limiares de exposi√ß√£o/oxida√ß√£o do LDL: acima de 0,8 h√° maior exposi√ß√£o do LDL √† oxida√ß√£o; alvo desej√°vel ‚â§0,7‚Äì0,8.
- Evid√™ncia hist√≥rica (Interarte, 2004) e revis√µes recentes (2023) sustentam a evolu√ß√£o do conhecimento sobre D, resist√™ncia √† insulina e risco cardiovascular.
- Lp(a) tem ~90% de variabilidade gen√©tica, indicando forte determina√ß√£o heredit√°ria e necessidade de estrat√©gias espec√≠ficas.
- Semaglutida em IC diast√≥lica e obesidade: estudo com n=529 mostrou redu√ß√£o de peso de 10% e apenas 1 evento de morte por IC no grupo tratado, sugerindo benef√≠cio cl√≠nico.

---

### Chunk 29/30
**Article:** Abordagem Funcional Integrativa Aplicada a Cada √Årea - Parte XIII (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.472

co da dislipidemia.
- [ ] 2. Analisar criticamente os estudos sobre o Inclisiran (Cibrava), focando na diferen√ßa entre desfechos substitutos (redu√ß√£o de LDL) e desfechos cl√≠nicos duros (mortalidade, infarto, AVC).
- [ ] 3. Utilizar o site `the-nnt.com` para pesquisar o NNT e NNH de outros medicamentos prescritos na pr√°tica cl√≠nica.
- [ ] 4. Refletir sobre a influ√™ncia da ind√∫stria farmac√™utica e dos interesses financeiros na prescri√ß√£o de novos medicamentos.
- [ ] 5. Estudar a diferen√ßa entre risco relativo e risco absoluto para interpretar criticamente os achados de estudos cient√≠ficos.
- [ ] 6. Pesquisar sobre os diferentes tipos de √¥mega-3 (EPA, DHA, ALA) e suas formula√ß√µes para entender como a qualidade do suplemento afeta os resultados.
- [ ] 7. Investigar os exames de subfracionamento de LDL e a rela√ß√£o ApoA/ApoB como ferramentas de avalia√ß√£o de risco cardiovascular mais precisas que o LDL total.
- [ ] 8.

---

### Chunk 30/30
**Article:** EuropeanJournalofHeartFailure(2023)25,1891‚Äì1898POSITIONPAPERdoi:10.1002/ejhf.3036 (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.472

alDenitionofHeartFailure:EndorsedbytheCanadianHeart
FailureSociety,HeartFailureAssociationofIndia,CardiacSocietyofAustralia
andNewZealand,andChineseHeartFailureAssociation.EurJHeartFail2021;23:352‚Äì380.https://doi.org/10.1002/ejhf.21157.ChioncelO,LainscakM,SeferovicPM,AnkerSD,Crespo-LeiroMG,HarjolaVP,etal.Epidemiologyandone-yearoutcomesinpatientswithchronicheartfailureandpreserved,mid-rangeandreducedejectionfraction:AnanalysisoftheESCHeartFailureLong-TermRegistry.EurJHeartFail2017;19:1574‚Äì1585.https://doi.org/10.1002/ejhf.8138.MukoyamaM,NakaoK,HosodaK,SugaS,SaitoY,OgawaY,etal.Brainnatriureticpeptideasanovelcardiachormoneinhumans.Evidenceforan
exquisitedualnatriureticpeptidesystem,atrialnatriureticpeptideandbrain
natriureticpeptide.JClinInvest1991;87:1402‚Äì1412.https://doi.org/10.1172/JCI1151469.PembertonCJ,JohnsonML,YandleTG,EspinerEA.Deconvolutionanalysisofcardiacnatriureticpeptidesduringacutevolumeoverload.Hypertension2000;36:355‚Äì359.https://doi.org/10.1161/01.hyp.36.3.35510.M

---

